LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | - | - | 55.3 | 312.0 | 1211.3 | 121.7 | 9.7 | 1710 |
1 | - | - | - | - | - | 0.3 | 0.7 | 1.7 | 2.0 | 0.3 | 5 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 0.3 |
1 | 0.3 |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 792.3 |
1 | 724.7 |
Number of post synapses: 5130
Number of pre synapses: 15
Number of output connections: 43
Coverage factor: 1.2
Columnar completeness: 0.48
Area completeness: 0.56
Cell size (columns): 123
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#MeVP18 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Pm9 (R) | GABA | 1,107 | 369.0 | 21.6% | 21.6% |
1 | Pm12 (R) | Glu | 606 | 202.0 | 11.8% | 33.5% |
2 | MeLo8 (R) | GABA | 326 | 108.7 | 6.4% | 39.8% |
3 | Mi10 (R) | ACh | 325 | 108.3 | 6.4% | 46.2% |
4 | Cm3 (R) | GABA | 270 | 90.0 | 5.3% | 51.5% |
5 | Pm13 (R) | Glu | 213 | 71.0 | 4.2% | 55.6% |
6 | MeVPMe1 (L) | Glu | 187 | 62.3 | 3.7% | 59.3% |
7 | Pm8 (R) | GABA | 186 | 62.0 | 3.6% | 62.9% |
8 | TmY5a (R) | Glu | 183 | 61.0 | 3.6% | 66.5% |
9 | Tm38 (R) | ACh | 155 | 51.7 | 3.0% | 69.5% |
10 | MeVC3 (L) | ACh | 150 | 50.0 | 2.9% | 72.5% |
11 | MeVPMe1 (R) | Glu | 130 | 43.3 | 2.5% | 75.0% |
12 | MeLo3b (R) | ACh | 97 | 32.3 | 1.9% | 76.9% |
13 | Tm3 (R) | ACh | 74 | 24.7 | 1.4% | 78.3% |
14 | Mi15 (R) | ACh | 66 | 22.0 | 1.3% | 79.6% |
15 | Y14 (R) | Glu | 60 | 20.0 | 1.2% | 80.8% |
16 | Tm31 (R) | Glu | 54 | 18.0 | 1.1% | 81.8% |
17 | TmY17 (R) | ACh | 48 | 16.0 | 0.9% | 82.8% |
18 | MeLo14 (R) | Glu | 41 | 13.7 | 0.8% | 83.6% |
19 | Pm4 (R) | GABA | 33 | 11.0 | 0.6% | 84.2% |
20 | Cm34 (R) | Glu | 32 | 10.7 | 0.6% | 84.9% |
21 | Cm4 (R) | Glu | 31 | 10.3 | 0.6% | 85.5% |
22 | Tm20 (R) | ACh | 30 | 10.0 | 0.6% | 86.0% |
23 | Cm6 (R) | GABA | 29 | 9.7 | 0.6% | 86.6% |
24 | Tm6 (R) | ACh | 28 | 9.3 | 0.5% | 87.2% |
25 | Pm10 (R) | GABA | 27 | 9.0 | 0.5% | 87.7% |
26 | aMe17e (R) | Glu | 26 | 8.7 | 0.5% | 88.2% |
27 | Tm4 (R) | ACh | 22 | 7.3 | 0.4% | 88.6% |
28 | MeLo7 (R) | ACh | 20 | 6.7 | 0.4% | 89.0% |
29 | TmY19a (R) | GABA | 18 | 6.0 | 0.4% | 89.4% |
30 | Dm2 (R) | ACh | 17 | 5.7 | 0.3% | 89.7% |
31 | MeLo10 (R) | Glu | 14 | 4.7 | 0.3% | 90.0% |
32 | MeLo4 (R) | ACh | 14 | 4.7 | 0.3% | 90.3% |
33 | Pm2b (R) | GABA | 14 | 4.7 | 0.3% | 90.5% |
34 | MeVP6 (R) | Glu | 13 | 4.3 | 0.3% | 90.8% |
35 | Mi4 (R) | GABA | 13 | 4.3 | 0.3% | 91.0% |
36 | Mi16 (R) | GABA | 12 | 4.0 | 0.2% | 91.3% |
37 | MeVC_unclear (R) | Glu | 11 | 3.7 | 0.2% | 91.5% |
38 | OA-AL2i1 (R) | OA | 11 | 3.7 | 0.2% | 91.7% |
39 | Cm5 (R) | GABA | 10 | 3.3 | 0.2% | 91.9% |
40 | MeTu3a (R) | ACh | 10 | 3.3 | 0.2% | 92.1% |
41 | Mi2 (R) | Glu | 10 | 3.3 | 0.2% | 92.3% |
42 | Pm2a (R) | GABA | 10 | 3.3 | 0.2% | 92.5% |
43 | Cm14 (R) | GABA | 9 | 3.0 | 0.2% | 92.7% |
44 | T2a (R) | ACh | 9 | 3.0 | 0.2% | 92.8% |
45 | Tm5Y (R) | ACh | 9 | 3.0 | 0.2% | 93.0% |
46 | TmY13 (R) | ACh | 9 | 3.0 | 0.2% | 93.2% |
47 | Y12 (R) | Glu | 9 | 3.0 | 0.2% | 93.4% |
48 | Y3 (R) | ACh | 9 | 3.0 | 0.2% | 93.5% |
49 | Mi9 (R) | Glu | 8 | 2.7 | 0.2% | 93.7% |
50 | Tm29 (R) | Glu | 8 | 2.7 | 0.2% | 93.8% |
51 | Tm5c (R) | Glu | 8 | 2.7 | 0.2% | 94.0% |
52 | 5-HTPMPV03 (R) | 5HT | 7 | 2.3 | 0.1% | 94.1% |
53 | MeVP17 (R) | Glu | 7 | 2.3 | 0.1% | 94.3% |
54 | Mi19 (R) | 5HT | 7 | 2.3 | 0.1% | 94.4% |
55 | TmY21 (R) | ACh | 7 | 2.3 | 0.1% | 94.5% |
56 | TmY9a (R) | ACh | 7 | 2.3 | 0.1% | 94.7% |
57 | Cm24 (R) | Glu | 6 | 2.0 | 0.1% | 94.8% |
58 | Cm7 (R) | Glu | 6 | 2.0 | 0.1% | 94.9% |
59 | MeLo1 (R) | ACh | 6 | 2.0 | 0.1% | 95.0% |
60 | MeLo3a (R) | ACh | 6 | 2.0 | 0.1% | 95.2% |
61 | MeLo6 (R) | ACh | 6 | 2.0 | 0.1% | 95.3% |
62 | MeTu4e (R) | ACh | 6 | 2.0 | 0.1% | 95.4% |
63 | MeVC21 (R) | Glu | 6 | 2.0 | 0.1% | 95.5% |
64 | OA-AL2i2 (R) | OA | 6 | 2.0 | 0.1% | 95.6% |
65 | TmY10 (R) | ACh | 6 | 2.0 | 0.1% | 95.7% |
66 | TmY19b (R) | GABA | 6 | 2.0 | 0.1% | 95.9% |
67 | MeLo11 (R) | Glu | 5 | 1.7 | 0.1% | 96.0% |
68 | MeTu3b (R) | ACh | 5 | 1.7 | 0.1% | 96.1% |
69 | MeVC4b (L) | ACh | 5 | 1.7 | 0.1% | 96.2% |
70 | MeVP14 (R) | ACh | 5 | 1.7 | 0.1% | 96.2% |
71 | MeVP3 (R) | ACh | 5 | 1.7 | 0.1% | 96.3% |
72 | MeVP4 (R) | ACh | 5 | 1.7 | 0.1% | 96.4% |
73 | OLVC5 (R) | ACh | 5 | 1.7 | 0.1% | 96.5% |
74 | Tm16 (R) | ACh | 5 | 1.7 | 0.1% | 96.6% |
75 | Tm32 (R) | Glu | 5 | 1.7 | 0.1% | 96.7% |
76 | TmY18 (R) | ACh | 5 | 1.7 | 0.1% | 96.8% |
77 | Y11 (R) | Glu | 5 | 1.7 | 0.1% | 96.9% |
78 | 5-HTPMPV03 (L) | 5HT | 4 | 1.3 | 0.1% | 97.0% |
79 | C3 (R) | GABA | 4 | 1.3 | 0.1% | 97.1% |
80 | Cm8 (R) | GABA | 4 | 1.3 | 0.1% | 97.2% |
81 | Cm9 (R) | Glu | 4 | 1.3 | 0.1% | 97.2% |
82 | MeLo9 (R) | Glu | 4 | 1.3 | 0.1% | 97.3% |
83 | MeTu4c (R) | ACh | 4 | 1.3 | 0.1% | 97.4% |
84 | MeTu4f (R) | ACh | 4 | 1.3 | 0.1% | 97.5% |
85 | MeVC2 (L) | ACh | 4 | 1.3 | 0.1% | 97.6% |
86 | MeVP2 (R) | ACh | 4 | 1.3 | 0.1% | 97.6% |
87 | MeVP30 (R) | ACh | 4 | 1.3 | 0.1% | 97.7% |
88 | MeVPMe2 (R) | Glu | 4 | 1.3 | 0.1% | 97.8% |
89 | Tm36 (R) | ACh | 4 | 1.3 | 0.1% | 97.9% |
90 | TmY14 (R) | Glu | 4 | 1.3 | 0.1% | 97.9% |
91 | Cm13 (R) | Glu | 3 | 1.0 | 0.1% | 98.0% |
92 | LC14b (L) | ACh | 3 | 1.0 | 0.1% | 98.1% |
93 | Li20 (R) | Glu | 3 | 1.0 | 0.1% | 98.1% |
94 | MeLo5 (R) | ACh | 3 | 1.0 | 0.1% | 98.2% |
95 | MeVP10 (R) | ACh | 3 | 1.0 | 0.1% | 98.2% |
96 | MeVP51 (R) | Glu | 3 | 1.0 | 0.1% | 98.3% |
97 | Mi1 (R) | ACh | 3 | 1.0 | 0.1% | 98.4% |
98 | OA-AL2i4 (R) | OA | 3 | 1.0 | 0.1% | 98.4% |
99 | OA-ASM1 (L) | OA | 3 | 1.0 | 0.1% | 98.5% |
100 | OA-ASM1 (R) | OA | 3 | 1.0 | 0.1% | 98.5% |
101 | TmY4 (R) | ACh | 3 | 1.0 | 0.1% | 98.6% |
102 | Y13 (R) | Glu | 3 | 1.0 | 0.1% | 98.7% |
instance | NT | total connections | connections /#MeVP18 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | MeLo7 (R) | ACh | 4 | 1.3 | 6.7% | 6.7% |
1 | Mi2 (R) | Glu | 4 | 1.3 | 6.7% | 13.3% |
2 | aMe17c (R) | Glu | 3 | 1.0 | 5.0% | 18.3% |
3 | Mi13 (R) | Glu | 3 | 1.0 | 5.0% | 23.3% |
4 | Pm2b (R) | GABA | 3 | 1.0 | 5.0% | 28.3% |